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ABSTRACT
The product of varicella-zoster virus gene 62 (VZV
140k) Is a potent transactivator protein. We have
Identified a region within the DNA binding domain of
VZV 140k that shows a striking similarity to the DNA
recognition helix of the homeodomain, with an
especially highly conserved quartet of residues, WLQN.
The 140k protein has functional counterparts within the
other alphaherpesvlruses, which Include the major
transcrlptlonal regulatory protein of HSV-1, (ICP4), and
the WLQN region is highly conserved among the
members of this family of viral transactlvators.
Substitution of VZV 140k residue lysine 548, just
adjacent to the WLQN region, drastically reduces the
DNA binding activity of the 140k DNA binding domain
and the Intact 140k mutant protein fails to activate gene
expression. Substitutions of two other VZV 140k
residues in this conserved WLQN region result In
alterations to the DNA binding Interaction and reduced
transactivation activities. All three mutations act at the
level of DNA recognition, as they have no apparent
effect on the dimerizatlon state, solubility or efficiency
of expression of the mutant peptides.
INTRODUCTION
Varicella-zoster virus (VZV) is a neurotropic alphaherpesvirus
and is the causative agent of chickenpox and shingles in humans.
The other members of the alphaherpesvirus family include herpes
simplex virus types 1 and 2 (HSV-1 and HSV-2), pseudorabies
virus (PRV) and equine herpesvirus type 1 (EHV-1). The
complete genomic nucleotide sequences of HSV-1, VZV and
EHV-1 have been derived (1—3) and they exhibit similar genomic
organisation and many of the gene products have conserved amino
acid sequences and similar locations within the genome. Much
of our current understanding of alphaherpesvirus gene regulation
has been derived from the intensively studied HSV-1 prototype
system. The 75 HSV-1 genes are regulated in a complex temporal
cascade and the genes are classified as immediate-early (IE), early
(E) or late (L) (for reviews, see 4,5). The transcription of the
five IE genes occurs without prior viral protein synthesis and
is induced by VP16, a component of the infecting virus particle
(6). At least three of the HSV-1 IE gene products encode
important transactivators that are essential for progression to the
E and L phases of the transcriptional cascade (7). The product
of the IE3 gene, ICP4, is considered to be the major
transcriptional regulatory protein of HSV-1 because ICP4 is
absolutely required for transactivation of E and L gene expression
(8,9) and also for autoregulation of its own HSV-1 IE3 promoter
(10-12).
Protein homologues of HSV-1 ICP4 have been identified in
the other alphaherpesviruses on the basis of predicted amino acid
sequence homology. These include the 140k protein of VZV (2),
the IE1 protein of EHV-1 (13) and the IE 180 protein of PRV
(14). The product of VZV gene 62, 140k, is a large protein
containing 1,310 amino acid residues, having a predicted
molecular mass of 140.000D. VZV 140k can functionally
substitute for HSV-1 ICP4 (15,16), indicating that 140k is likely
to play an essential role in the VZV life cycle, equivalent to that
played by HSV-1 ICP4. In transient transfection experiments,
VZV 140k is a potent transactivator of VZV putative early and
late genes and some heterologous genes (17-20). 140khas been
reported to either autoregulate or transactivate its own gene 62
promoter in transient transfection assays, depending on the cell
type used (21,22).
The primary sequence of the VZV 140k protein and its
homologues in the other alphaherpesviruses have been divided
conceptually into five colinear regions on the basis of the degree
of amino acid similarity between them (23,13,14). The HSV-1
ICP4 protein binds directly to DNA (24) and its DNA binding
activity is abolished by small (2 -4 amino acid) insertion
mutations at positions throughout the highly conserved region
2 and the C-terminal end of the less well conserved region 1 of
the protein (25,26). Subsequently, it was found that peptides
spanning these regions of HSV-1 ICP4, and the equivalent regions
of the VZV 140k and PRV IE180 proteins, yield stable,
physically separable (27) DNA binding domains, when expressed
in isolation in bacteria (28-31). The ICP4 protein, and its isolated
DNA binding domain, recognizes various DNA binding sites that
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conform (to a greater or lesser extent) (32) to the bipartite ICP4
consensus sequence ATCGTCnnnnYCGRC (33,28,34). In
addition, the VZV 140k DNA binding domain can also bind to
ICP4 consensus binding sites and many of the 140k binding sites
recognised within its own VZV gene 62 promoter show some
similarity to the ICP4 consensus, although the 140k domain is
less sequence specific than that of ICP4 (31). The 140k DNA
binding domain interacts with its DNA binding sites as a stable
homodimer (35) and DNA binding is likely to be a requirement
for the transactivation and repression functions of 140k, as an
insertion of four amino acids into region 2 renders the protein
functionally inactive (21).
Structural studies and sequence comparisons have found that
many DNA binding proteins can be grouped into classes that use
related structural motifs for DNA recognition (for reviews, see
36,37). Like several other important viral transactivator proteins,
for instance SV40 large T antigen (38), the VZV 140k DNA
binding domain does not contain sequences that fit neatly into
any of the recognised classes of DNA binding motif. However,
we have identified a short region of sequence showing significant
homology to the DNA recognition helix (helix 3) of the
homeodomain DNA binding motif. Homeodomains have been
found in proteins of virtually all eukaryotes examined, ranging
from yeast to man (39,40) where they play central roles in gene
regulation. The homeodomain is structurally related to the
prokaryotic helix-tum-helix (HTH) motif, and typically comprises
60 residues arranged in three a-helical segments, helices 2 and
3 comprise the HTH, and the third helix is the principal
determinant for DNA recognition. Recently, numerous highly
divergent classes of homeodomains / eukaryotic HTH proteins
have been discovered (for reviews, see 40,41). Studies on non-
classical homeodomains, such as the dimeric hepatocyte
transcription factor HNF1 (or LFB1) (42) reveal their almost
identical spatial arrangement of helices to those found in the
corresponding HTHs of the more typical Drosophila
engrailed(en) (43) and yeast MATa2 (44) homeodomains, despite
their very low level of sequence identity outside of the recognition
helix.
The WLQN region of homology to the homeodomain
recognition helix that we describe in this paper lies towards the
centre of the 140k DNA binding domain (residues 537-553)
and is highly conserved among the other alphaherpesvirus
transactivator homologues. Residues both within and flanking the
WLQN region, corresponding to those that make critical
homeodomain-DNA contacts, are also well conserved. Although
the presence of proline 'helix-breaking' residues in the WLQN
region of 140k suggest that this sequence is unlikely to adopt
a structure precisely equivalent to that of the homeodomain, we
decided to analyse the possible functional implications of the
conservation of the WLQN region by mutagenesis of the VZV
140k sequence. The results presented here provide evidence that
residues within this WLQN homology region are directly
involved in DNA recognition and are required for the
transactivation function of the 140k protein.
MATERIALS AND METHODS
Bacteria and cells
Plasmids were constructed and maintained in E. coli strain DH5a
using standard methods (45). For the bacterial expression
experiments, plasmids were transformed into E. coli strain BL21
(DE3) pLysS (46). Bacteriophage M13 derivatives were
transfected into E. coli strain TGI. The TGI host bacterium was
used for all subsequent growth and maintenance of M13
bacteriophage. HeLa cells were grown in Dulbecco's Modified
Eagle's Medium (DMEM) supplemented with lOOunits/ml
penicillin, 100/jg/ml streptomycin, 2.5% (v/v) newborn calf
serum and 2.5% (v/v) foetal calf serum. Baby hamster kidney
cells (BHK-21 clone 13) (47) were grown in Glasgow MEM
(Gibco) supplemented with lOOunits/ml penicillin, 100/ig/ml
streptomycin, 10% (v/v) tryptose phosphate and 10% (v/v)
newborn calf serum.
Oligonucleotide directed mutagenesis
The oligonucleotides given in Figure IB (incorporating novel
restriction enzyme sites, HindSl, PvuU and Sacl respectively)
were created using a Cruachem synthesiser to enable substitution
of single VZV 140k residues; Q545L, N546L and K548E
respectively. Oligonucleotides were purified by gel
electrophoresis, phosphorylated and used in mutagenesis reactions
using the Amersham M13 mutagenesis system (Version 2). The
template for mutagenesis was single stranded bacteriophage
M13mpl8EK, which contains the VZV gene 62 EcoRl-Kprii
fragment isolated from plasmid p585T7aVT2X (see below)
cloned into the EcoRI-Kpnl sites of the multiple cloning region
of the M13mpl8 vector. After mutagenesis, the reactions were
transfected into competent TGI bacteria and plaques picked for
screening. Positive bacteriophage M13Q545L, M13N546L and
M13K548E were identified by restriction enzyme digestion at
the introduced restriction sites and confirmed by direct plasmid
sequencing of the mutated region.
Construction of plasmids expressing mutants of the 140k DNA
binding domain and intact 140k peptides
Plasmid p585T7a was adapted from the pET-8c T7 expression
vector (46) to facilitate insertion of DNA fragments and then-
subsequent in-frame expression as described (31). Plasmid
p585T7aVT2X was a derivative of p585T7a and included VZV
gene 62 nucleotide sequences encompassing codons 417 to 647
(31). Plasmid p585T7aVT2X expressed the 140k DNA binding
domain peptide, referred to as VT2X (Fig. 2A), which had a
predicted molecular mass of 26.7kD. Plasmids pVT2XQ545L,
pVT2XN546L and pVT2XK548E were derived from plasmid
p585T7aVT2X as described below and express versions of the
VT2X peptide containing single amino acid substitutions as
described by the name of each plasmid. EcoRl-Kpnl fragments
carrying gene 62 sequences containing specific nucleotide changes
incorporated by oligonucleotide-directed mutagenesis were
isolated from replicative forms of die M13 bacteriophage
M13Q545L, M13N546L and M13K548E. Each mutated £coRI-
Kpnl fragment was ligated into the EcoKL-Kpnl digested
p585T7aVT2X plasmid; the digested vector fragment had
previously been isolated away from the wild type EcoKl-Kpnl
fragment using agarose gel electrophoresis and GENECLEANII
(BIO 101 Inc., La Jolla) procedures. This cloning procedure
produced plasmids pVT2XQ545L, pVT2XN546L and
pVT2XK548E; direct plasmid sequencing was used to confirm
the incorporation of the intended nucleotides and also the
sequences spanning the EcoRl and Kpnl junctions.
Plasmid pl40 contained die entire VZV gene 62 open reading
frame and promoter region on the Clal-Pstl fragment of plasmid
pVZVSstf (17) in a pUC9 background as described (48).
Nucleotide changes introduced by oligonucleotide-directed
mutagenesis were incorporated into the intact gene 62 open
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reading frame as follows: Narl-Kpnl fragments isolated from
plasmids pVT2XQ545L, pVT2XN546L and pVT2XK548E were
each co-ligated with three fragments (Kpnl-Pstl fragment,
2414bp; PsA-SpHi. fragment, 4572bp; Sphl-Narl fragment, 632bp)
isolated from plasmid pl40. The resultant positive plasmids
pl40Q545L, pl40N546L and pl40K548E were identified by
extensive restriction enzyme digest analysis using the restriction
sites introduced by the mutagenesis procedure.
Expression and partial purification of the VZV 140k DNA
binding domain
E. coli strain BL21 (DE3) pLysS transformed with the T7
expression vectors were grown up, induced, harvested and crude
35% ammonium sulphate cut extracts prepared from 100ml
cultures exactly as described (31). Samples of the lysed bacteria
after induction and the final crude extract were analysed by 12.5%
SDS PAGE followed by Coomassie blue staining. The relative
amounts of the mutant and wild type VT2X peptides in the
partially purified extracts were determined by scanning
densitometry for each set of protein preparations; equivalent
amounts of the peptides were included in the DNA binding
analyses (below).
DNA fragment probes
The following DNA restriction fragment probes, radiolabelled
at a single fragment end, were used for DNA binding analyses:
The VZV gene 62 promoter probe fragment (31) encompassed
sequences -130 to +57 of gene 62. The HSV-1 IE3 promoter
probe (35) encompassed nucleotides —18 to +27 of the IE3 gene
and includes the strong consensus ICP4 binding site spanning
the mRNA start site (49). The HSV-1 gD promoter probe
encompassed nucleotides —262 to +11 and was derived from
a PvuU-Hindm fragment of the HSV-1 glycoprotein D (gD)
promoter as follows: plasmid pgDCAT (50) was cut with HindM
and the overhang filled in by Klenow enzyme in the presence
of a32P-dATP, followed by digestion with PvwII. The labelled
PvuE-HindUl fragment which includes the ICP4 consensus
binding site upstream of the gD mRNA start site (33) was eluted
from a 5% polyacrylamide gel and purified by ethanol
precipitation.
DNA binding analyses
Appropriate amounts of partially purified bacterial extracts (see
legend to Fig. 3)were incubated on ice with Ing of radiolabelled
DNA fragment probes for 20min and the products resolved by
native gel electrophoresis essentially as described (31). In these
experiments 0.5/xg of pUC9 was included in each incubation
instead of the polydl.polydC non-specific competitor.
Determination of site specific protection of 4ng radiolabelled
DNA fragments from partial DNase I digestion, by the partially
purified bacterial extracts of wild type and mutant VT2X peptides
(amounts as given in legend to Fig. 4), was exactly as described
previously (31).
DNA transfection and CAT assay
HeLa cells were seeded at 106 cells per 50mm petri dish and
were transfected by the calcium phosphate precipitation method
24hr later (51). The reporter plasmid pgDCAT contains the
HSV-1 gD promoter / leader sequences fused to the chloram-
phenicol acetyl-transferase (CAT) open reading frame.
Transfections used 4/tg of the pgDCAT plasmid and variable
amounts of the pi40 derived effector plasmids; pUC9 was used
to equalise the amount of DNA within experiments. After a further
24hr the cells were washed and re-fed with fresh medium; 24hr
later total cell extracts were prepared and CAT activities were
assayed as described by Gorman (52). The radioactivity in the
substrate and product was quantitated using a Phosphorlmager
scanner with Image-Quant software (Molecular Dynamics). The
protein concentration of HeLa cell extracts was determined using
the Bio-Rad protein assay reagent according to the manufacturer's
instructions, in order to calculate the percentage conversion from
substrate to product per microgram protein.
Immunofluorescence
BHK cells were seeded at 5 x 105 cells per 50mm petri dish and
24hr later were transfected with 6/ig of plasmid pi40 or its
derivatives using a liposome-mediated DNA transfection
procedure (53) as described (54). 24hr after transfection, the cells
were washed and re-fed. After a further 24hr the cells were fixed,
permeabilised and stained for immunofluorescence essentially as
described (55). The rabbit polyclonal antiserum 109 was used
at a dilution of 1:500 in PBS as the primary antibody, then
fluorescein isothiocyanate-conjugated goat anti-rabbit immuno-
globulin was used to detect bound antibody before examination
by UV fluorescent microscopy. Polyclonal 109 was raised against
the bacterially expressed 140k DNA binding domain peptide
VT2, which had been highly purified by column chromatography
(35).
Computer analysis
Protein sequences were aligned using programmes from the
Sequence Analysis Software Package (Genetics Computer Group,
Inc., Madison, Wis.).
RESULTS
Identification of a region of sequence homology to the
homeodomain recognition motif
The minimum defined DNA binding domains of the VZV 140k
(31) and HSV-1 ICP4 (28,29) proteins are fairly large (162 and
216 residues respectively) compared to the sizes of the recognised
classes of DNA binding domain structures so far determined
(36,37). We have been interested in defining specific sequences
within these large protein domains that mediate the DNA
recognition function of the alphaherpesvirus regulatory proteins.
A comparative analysis of the sequences of the VZV 140k
homologue proteins with the various established classes of DNA
binding motifs has identified a sequence (referred to as the WLQN
region) showing significant similarity to the homeodomain DNA
recognition helix. The WLQN region of homology is roughly
in the centre of the defined DNA binding domain of the VZV
140k and HSV-1 ICP4 proteins and is highly conserved within
the alphaherpesvirus family.
The numerous homeodomains that have been described fall
into distinct groups, residues at several positions are significantly
conserved throughout all the homeodomain groups, but the
remaining residues show considerable divergence (39,40). In
essence, the homeodomain is a structural fold carrying the DNA
recognition helix. Figure 1A shows the recognition helix of the
prototype Group 7 Drosophila Antennapedia (Antp) homeo-
domain aligned with the homology region identified within the
VZV 140k alphaherpesvirus homologues. The asterisks in Figure
1A indicate positions that are invariant or nearly invariant within
the homeodomains. These residues are also conserved or semi-
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Figure 1. The WLQN region and its mutational analysis in the VZV 140k protein
A. Alignment of the recognition helix of the Drosophila Antp homeodomain to
the alphaherpesvirus homologues of VZV 140k. The top sequence shows thzAntp
recognition helix (homeodomain helix 3). Amp amino acids are numbered according
to convention to indicate their position in the 60-residue homeodomain (40).
Positions corresponding to the hydrophobic core (H), base contact (B) and
phosphate contact (P) amino acids of the Antp (56) MAT<*2 (44) and en (43)
homeodomain structures are indicated above the Antp sequence. Positions that
are invariant or nearly invariant within all known homeodomains are indicated
with asterisks. Alphaherpesvirus region 2 sequences are aligned beneath. The
VZV 140k residues that were subject to mutation are shown in bold. B.
Oligonucleotides used for oligonucleotide-directed mutagenesis of VZV 140k.
At the top is shown the wild type protein sequence and the sequences of both
gene 62 DNA strands which encompass the region of mutagenesis. Below are
given the three oligonucleotides (corresponding to the gene 62 non-coding strand)
and the relevant coding potentials. The nucleotides that differ from the wild type
sequence and the resultant amino acid residue alterations are shown in bold.
Restriction enzyme sites introduced by taking advantage of the degenerate nature
of the genetic code are also indicated.
conserved within the alphaherpesvirus proteins. The structures
determined for three homeodomain-DNA complexes (43,44,56)
demonstrate that the invariant residues either mediate specific
DNA contacts or maintain the hydrophobic core contacts that
stabilise the homeodomain protein fold, as indicated in Figure
1A. However, unlike the homeodomain recognition helix, the
WLQN region of 140k is unlikely to be folded into a single
uninterrupted a-helix due to the presence of proline residues at
amino acids 540 and 547, but could quite possibly adopt two
helical turns between residues 540 and 547 and resume a helical
conformation after residue 547.
Mutagenesis, expression and purification of the 140k DNA
binding domain
We were interested to investigate whether this potentially
interesting WLQN region might mediate DNA recognition by
the VZV 140k family of proteins. We used in vitro mutagenesis
to alter the charges on specific VZV 140k residues, while
maintaining the size of the amino acid side chains to minimise
conformational alterations in the protein. We mutated two single
conserved residues within the WLQN motif itself: The 140k
residue Gin 545 was replaced with Leu (Q545L) and residue Asn
546 was replaced with Leu (N546L). The corresponding residues
of the homeodomain, residues 50 and invariant Asn 51 (Fig. 1A),
both point into the major DNA groove and hydrogen bond with
DNA bases, in the known homeodomain-DNA structures. In
addition, genetic and biochemical analyses have shown the residue
VZV 140k
K54S
[ t H | 5 |
DNA binding
domain-VT2X n—i
417 647
1 2 3 4 5 6 7 8 9 10 11
Figure 2. The location of the VZV 140k DNA binding domain and its expression
in bacteria. A. Diagrammatic representations of VZV 140k and its DNA binding
domain peptide, VT2X. The sequences of regions 2 and 4 are highly conserved
(46% and 56% identity respectively) between VZV 140k and HSV-1 ICP4 (23)
and are shown shaded, amino acid coordinates of the boundaries of the conserved
regions are given (inclusively). Regions 1, 3 & 5 are less highly conserved between
the two proteins (15-25% identity). The VT2X peptide contains VZV 140k
residues 417 to 647 (31), encompassing the highly conserved region 2. The arrow
indicates the position of the three residues whose substitution is discussed in the
text. B. Coomassie-stained 12.5% SDS PAGE analysis of the partial purification
of bacterially expressed wild type and mutant VT2X peptides. Expression of 140k
DNA binding domain peptides was induced in E. coli from the appropriate T7
expression plasmids (Materials & Methods). Tracks 1 —5 contain 2/d of the total
soluble proteins from 100ml of each induced bacterial culture after resuspension
in lml buffer, bacterial lysis and centrifugation (31). Tracks 6-10 contain 2/d
of partially purified extracts after 35% ammonium sulphate precipitates were
resuspended in 300;d buffer, 'con' is an extract prepared from induced bacteria
carrying the p585T7a plasmid. The arrow shows the position of the 26.7kD VT2X
peptide; a smaller proteolytic degradation product is apparent beneath. Track 11
contains molecular weight standards: BSA, 66kD; albumin, 45kD;
glyceraldehyde-3-phosphate dehydrogenase, 36kD; carbonic anhydrase, 29kD;
trypsinogen, 24kD; trypsin inhibitor, 20.1kD.
at homeodomain position 50 determines the differential binding
specificity of the homeodomain-DNA interaction (57-59). For
the third mutation, we chose to replace VZV 140k residue Lys
548 with Glu (K548E), due to the conservation of a basic residue
at this position in the alphaherpesvirus proteins and also the
homeodomains. The corresponding homeodomain residue Arg
53 forms critical hydrogen bonds with two phosphate groups of
the DNA backbone to stabilise the protein-DNA interaction.
The substitutions were initially introduced into a peptide
encompassing the VZV 140k DNA binding domain. This DNA
binding domain peptide, referred to as VT2X, encompasses 140k
residues 417 to 647 (Fig. 2A) and includes the highly conserved
protein region 2 (codons 468 to 641). These 140k sequences yield
a stable domain when expressed in isolation of other viral
sequences in E. coli using the T7 expression system, and is
capable of binding to DNA in a sequence specific manner (31).
Partially purified extracts of the wild type and mutant VT2X
peptides were produced as described (31). Figure 2B shows for
each peptide, samples of initial soluble (tracks 1 -5 ) and partially
 at U
niversity of G
lasgow
 on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
274 Nucleic Acids Research, 1994, Vol. 22, No. 3
VT2X VT2X VT2X
VT2X Q545L
 N M 6 L K 5 4 B E
I
PC
- • probe
1 2 3 4 B 8 7 S e 10 11 12 13 14
VZV Gena 62 promoter
B
P C * -
- • P C
- * proba
probe * -
1 2 3 4 5
HSV-1 IE3
promoter
7 s s 10 11
HSV-1 gD
promoter
VZV Gena 62
promoter
HSV-1 IE3
promoter
HSV-1 gD
promoter
Figure 3. Gel retardation analyses of the DNA binding activities of the mutant
140k DNA binding domain peptides A. A radiolabelled DNA fragment derived
from the VZV gene 62 promoter (Materials & Methods) was incubated with 25ng,
50ng or lOOng of the partially purified bacterial extracts of wild type or mutant
VT2X peptide indicated above tracks 3-14. The incubation reaction for track
1 contained no extract and track 2 contained a control extract prepared from bacteria
carrying the p585T7a expression vector. After incubation, the reactions were
electrophoretically separated on a native 4% polyacrylamide gel and prepared
for autoradiography (31). The positions of the free DNA probe, primary (PC)
and secondary (SC) protein-DNA complexes are indicated on the right-hand
side. B. Radiolabelled DNA fragments from the HSV-1 IE3 gene promoter (tracks
1 -6 ) and the HSV-1 gD early gene promoter (tracks 7—12) were incubated with
40ng and 30ng (respectively) of the partially purified bacterial extracts of the
VT2X derived peptides. The components of the reactions were resolved by
electrophoresis as above.
Figure 4. DNase I footprinting analyses of the DNA binding activities of the
mutant VZV 140k DNA binding domain peptides. DNase I footprinting assays
were performed with end-labelled gene promoter DNA fragments and partially
purified bacterial extracts as described (31). The wild type and mutant VT2X
tracks contained 1.6/jg of the DNA binding domain peptide indicated above the
tracks. Tracks labelled 'G+A', ' — ' and 'con' contain Maxam and Gilbert
sequencing reactions, no extract and induced bacterial extract carrying the p585T7a
vector respectively. The identity of the DNA probe fragment used for each
experiment is given beneath the panel (details given in the Materials and Methods
section). Radrolabelling of the VZV gene 62 promoter fragment was on the bottom
DNA strand, the HSV-1 IE3 and gD promoter fragments were labelled on the
top strand. The numbered scale on the left of each panel identifies the positions
of nucleotides included within each DNA fragment; numbered with respect to
the mRNA start site (+1). The bent arrows indicate proposed mRNA start sites.
The positions and sequences of the ICP4 consensus binding site over the HSV-1
IE3 gene mRNA start site (49) and also the ICP4 consensus site 5' of the HSV-1
gD mRNA start she (33) are indicated.
purified (tracks 6-10) bacterial extracts, following SDS PAGE
analysis and Coomassie-staining. The mutations did not effect
the efficiency of expression in bacteria, as all the peptides were
induced to high levels (Fig. 2B, tracks 2 -5) . In addition, all
the peptides were highly soluble indicating that the mutations did
not induce conformational disruptions leading to protein
precipitation.
Mutation of a lysine residue within the WLQN region severely
impairs sequence specific DNA binding by the 140k DNA
binding domain
The VZV 140k DNA binding domain binds various sequences
within its own VZV gene 62 promoter (31) including a site over
the mRNA start site that is thought to be involved in the
autoregulation of the gene 62 promoter at later times during
infection (30). Initially the mutant VT2X peptides were analyzed
for their abilities to recognise the gene 62 promoter in gel
retardation analyses (Fig. 3A). Incubation of an equivalent range
of amounts of each peptide with the gene 62 promoter probe
yielded primary protein—DNA complexes for wild type VT2X,
VT2XQ545L and VT2XN546L (Fig. 3A, tracks 3 - 5 , 6 - 8 ,
9—11 respectively) and secondary complexes were produced with
higher amounts of these peptides. Other experiments using in
vitro translated heterodimer polypeptides strongly suggest that
the simplest interpretation is that the primary complex
corresponds to a peptide dimer bound to DNA; additional
experiments have found that the 140k DNA binding domain
peptides exist totally in the dimeric form in solution and therefore
the secondary complexes are assumed to contain a pair of dimers
(35). The VT2X, VT2XQ545L and VT2XN546L peptides had
similar DNA binding affinities as determined by competition
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Figure 6. Expression of VZV 140k mutants in BHK cells. Plasmids expressing
A. 140k (pl40), B. 140Q545L (pl4OQ545L), C. 140N546L (pl40N546L), D.
140K548E (pl40K548E) and E. no plasmid were transfected into BHK cells and
stained with polyclonal anoserum to me VZV 140k DNA binding domain. Granular
and diffuse nuclear staining characteristic of the VZV 140k protein, is present
in A - D .
Figure 5. Transactivation efficiencies of the mutant VZV 140k proteins. The
graphs show data obtained from independent experiments measuring activation
of expression from HSV-1 gD promoter-leader sequences by the VZV 140k protein
and its mutant derivatives. Increasing amounts of each effector plasmid were co-
transfected with the reporter construct pgDCAT into HeLa cells, the symbols
corresponding to the effector plasmids expressing the gene 62 sequences are as
explained in the key. Fold induction promoter activity induced by each effector
plasmid was calculated by dividing the percentage conversion from substrate to
product per microgram protein obtained at a particular plasmid amount, by the
control value obtained when no effector plasmid was present (the control value
represented an average of three individual transfections). The fold induction for
each transfection is expressed as a percentage of the maximum induction induced
by 10/jg of plasmid pl40 (100%).
experiments (data not shown). The VT2XK548E peptide
produced a very faint, smeary protein-DNA complex with the
gene 62 promoter fragment (Fig. 3A, track 14) when included
at an amount which yielded secondary complexes with the other
three peptides. The greatly reduced DNA binding activity of
VT2XK548E could be accounted for by a lower DNA binding
affinity or unstable interactions with DNA, as a result of the
substitution.
The VZV 140k DNA binding domain peptide, VT2X, can also
recognise binding sites within HSV-1 gene promoters, including
sites fitting the ICP4 binding consensus (31,60). To analyze
whether the effects of the three mutations on DNA binding were
specific to sites within the gene 62 promoter, we investigated
whether the mutant VT2X peptides could recognise DNA
fragments from the HSV-1 ffi3 and HSV-1 glycoprotein D (gD)
promoters (Fig. 3B). Both of these probes contained ICP4
consensus binding sites (Fig. 4B & Q that are recognised by
wild type VT2X (31). This experiment used an equivalent amount
of each peptide that gave only the primary protein-DNA complex.
As seen above with the VZV gene 62 promoter fragment,
mutations Q545L and N546L had little effect on the DNA binding
affinity of VT2X to either the IE3 or the gD probe (Fig. 3B),
although slight differences in the relative intensities of complexes
produced by these two mutant peptides, as compared to wild type
VT2X were seen on the three probe fragments. No detectable
binding of peptide VT2XK548E to the HSV-1 ffi3 promoter
fragment was observed (Fig. 3B, track 6) and a barely detectable
complex was seen on the gD promoter fragment (Fig. 3B, track
12). These consequences of mutation K548E are consistent with
the result on the VZV gene 62 promoter fragment (see above)
and indicate that the effects of this substitution are not specific
to the gene 62 promoter, but reflect a generalised disruption of
the VZV 140k DNA binding interaction.
The 140k DNA binding domain is a stable dimer and
dimerization appears to be a prerequisite for DNA binding (35).
Therefore, it was necessary to eliminate the possibility that
mutation K548E might act by disrupting dimerization rather than
affecting DNA binding directly. Aliquots of each mutant VT2X
peptide were analyzed by gel filtration chromatography as
described previously (35) and were all found to elute as single
discrete species with retention volumes identical to that of the
VT2X homodimer (data not shown). Therefore mutation of
residue K548 in the 140k WLQN region does not affect subunit
interaction, and is likely to interfere with DNA binding direcdy.
Mutations in the WLQN region alter DNA recognition by the
140k DNA binding domain
DNase I footprinting analysis was used to provide further
information about the effects of the mutations in the 140k WLQN
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region on the specificity of DNA binding. Particular care was
taken to ensure equal input of DNA binding domain peptides in
these experiments. Footprinting on the VZV gene 62 promoter
probe showed that VT2X provided characteristic protection of
multiple sequences from DNase I digestion, flanked by marked
sites of DNase I hypersensitivity (31); the most apparent
sequences protected by VT2X from DNase I digestion were
centred over the gene 62 mRNA start site, and around nucleotides
- 3 0 , - 5 0 and - 8 0 (Fig. 4A). Peptides VT2XQ545L and
VT2XN546L both provided protection for sequences similar to
those recognised by VT2X, albeit more faintly. This weaker
DNase I protection was not merely a consequence of reduced
DNA binding affinity (see above). These two mutant peptides
also induced sites of DNase I hypersensitivity in similar positions
to those produced with VT2X, although closer examination of
the VT2X, VT2XQ545L and VT2XN546L tracks reveals slight
differences in the details of these hypersensitivity sites. The
VT2XK548E peptide failed to produce any footprinting pattern,
although on comparison with the control track, it is apparent that
a degree of DNase I hypersensitivity was induced by this peptide
at similar positions to those produced by the other three peptides.
Perhaps peptide VT2XK548E interacts transiently with DNA,
but not so as to provide sequence specific protection or yield stable
protein-DNA complexes detectable by gel retardation assays.
Further DNase I footprinting experiments were performed upon
the same HSV-1 EE3 and gD promoter probes used in the gel
retardation analyses above (Fig. 3B). On the HSV-1 IE3 probe,
VT2X protected both halves of the bipartite consensus site and
faint protection extended beyond the 3' end of the consensus site
to nucleotide +25 (Fig. 4B). VT2XQ545L weakly protected
some similar sequences to those recognised by VT2X, although
on close comparison with the VT2X track, slight differences in
hypersensitivity and also in the DNase I protection pattern were
apparent. Interactions between the VT2XN546L and
VT2XK548E peptides and DNA was illustrated by the DNase
I hypersensitivity induced to the 5' of the consensus binding site
but there was little specific protection from DNase I digestion.
The HSV-1 gD promoter fragment contained multiple sequences
weakly recognised by VT2X, flanked by sites of DNase I
hypersensitivity (Fig. 4C). The sequences protected by VT2X
were centred over nucleotides —130, -100 (the consensus ICP4
binding site), - 4 5 and also to a lesser degree around nucleotide
— 85. The gD ICP4 consensus sequence (33) was weakly
recognised by VT2XQ545L and VT2XN546L, but not by
VT2XK548E. Examination of the sites of DNase I
hypersensitivity induced by VT2X and its mutant derivatives
demonstrates that the three mutant peptides had differing effects
on the details of the DNase I footprint on the HSV-1 gD promoter
fragment.
The lysine mutation that disrupts sequence specific DNA
recognition also destroys the transactivation function of 140k
Having found that amino acid substitutions within the WLQN
region affected, to varying degrees, the interaction of the isolated
VZV 140k DNA binding domain with DNA, we wanted to
analyze the effects of these mutations, if any, on the
transactivation function of the 140k protein. Each mutation was
incorporated into the intact 140k protein (Materials and Mediods),
and the transactivation efficiency of each mutant 140k protein,
as determined by CAT assay, was compared to that of wild type
140k. Transactivation of the HSV-1 glycoprotein D (gD)
promoter was measured in these experiments because VZV 140k
is an extremely potent activator of this particular promoter (61).
Additionally, die effects of the mutations on transactivation and
DNA binding can be compared directly, as the gD promoter
region was included in the DNA binding analyses above. For
each mutation, consistent alterations of the DNA binding
interaction was observed on all three promoters tested above;
therefore it is likely that the consequence of each mutation on
the regulatory functions of 140k, as measured on the HSV-1 gD
promoter, would apply to all target promoters. A range of
concentrations of each effector plasmid and a fixed amount of
the gD promoter-CAT reporter construct were transiently co-
transfected into HeLa cells. Graphical representations of the
results of two repeats of such an experiment are shown in Figure
5, and indicate the reproducibility of the effects of each mutation.
As anticipated, wild type VZV 140k very strongly transactivated
(up to 118 fold and 191 fold induction over plasmid pgDCAT
alone, for each graph in Fig. 5 respectively) the HSV-1 gD
promoter in a dose dependent manner. The 140Q545L protein
had a slighdy impaired transactivation efficiency, whereas the
reduction as a result of the N546L mutation was more pronounced
(Fig. 5). The 140K548E protein completely failed to activate gene
expression from the gD promoter. The lack of function of die
140K548E protein was not specific to the HSV-1 gD promoter
but represented a general phenomenon; 140K548E failed to
transactivate the HSV-1 IE1 and HSV-1 tk promoters, and also
the SV40 early promoter-enhancer regions (data not shown).
The fact that the isolated 140k DNA binding domain peptides
containing mutations within the WLQN region were stable,
soluble dimers (see above), suggests that conformational
alterations are not responsible for the altered DNA binding and
regulatory functions. To check diat the mutations had not
unfavourably affected expression or stability of the full length
140k proteins, we compared the immunofluorescence profiles
obtained for wild type and mutant 140k proteins. All four 140k
derivative proteins localised to the nucleus with the characteristic
distribution of nuclear staining (Fig. 6A-D). For each set of
transfections, similar intensity fluorescence was observed in
comparable numbers of cells for the wild type and mutant
proteins. Additionally, a polypeptide band with the same mobility
as wild type 140k was expressed to equivalent levels for each
mutant 140k peptide, as determined by western blot analysis of
extracts of transfected BHK cells (not shown). We conclude that
the mutations in the WLQN region were not deleterious to die
expression or stability of the 140k protein. Therefore, the
differential efficiencies of transactivation induced by the mutant
140k proteins were likely to be a consequence of their altered
DNA binding activities, as identified in the DNA binding analyses
above.
DISCUSSION
From the available functional data and by analogy with HSV-1
ICP4, the VZV 140k transactivator protein is likely to be
particularly important for the regulation of gene expression of
all proposed temporal classes of VZV genes (18,20-22). Again
by analogy with ICP4, VZV 140k is likely to act at the level
of transcriptional initiation (12). It is a reasonable assumption
diat the mechanisms underlying diese processes involve VZV
140k binding direcdy to DNA in a sequence specific manner.
The effects of mutating three single residues in a conserved
sequence within die 140k DNA binding domain, including the
residues WLQN, are consistent widi this WLQN region being
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directly involved in the DNA binding and transactivation
functions of VZV 140k.
The bacterially expressed isolated 140k DNA binding domain
provided a well characterised and convenient tool for the analysis
of the effects on DNA binding caused by mutations in the WLQN
region. Due to the poor growth characteristics of VZV in tissue
culture, the study of the intact 140k protein has been hampered
by the inability to obtain large enough amounts of 140k from
VZV infected cells for DNA binding analyses (61). However,
the 140k DNA binding domain has been closely defined and is
stably expressed in bacteria as a separable domain and further
post-translational modifications are not required for its sequence
specific DNA binding activity (31). At least for the homologous
HSV-1ICP4 protein, the isolated DNA binding domain peptide
has a very similar specificity to that of the intact protein (34).
By analogy, the consequence of point mutations in the WLQN
region on the binding activity of die 140k DNA binding domain
peptide are likely to reflect their effects upon the intact 140k
protein.
Replacement of VZV 140k residue lysine 548 with glutamic
acid (K548E) drastically reduced the sequence specific DNA
binding activity of the mutant 140k DNA binding domain, and
resulted in a non-functional intact 140k protein, as determined
by transient transfection assays. Given that no gross changes in
dimerization state, stability, solubility or efficiency of expression
were detected as a result of the K548E mutation, these findings
suggest that DNA binding is essential for the transactivation
function of the VZV 140k protein. The relationship between the
DNA binding and regulatory functions of the equivalent protein
of HSV-1, ICP4, is slighdy controversial. Detailed mutational
and functional analyses have shown that mutations which disrupt
the DNA binding activity of ICP4 abrogate its regulatory
functions (25,26,62), with one exception. This solitary case
comprised a pseudorevertant of an inactive ICP4 protein which
had restored regulatory activities (in the context of viral infection)
and impaired DNA binding properties (63). However, the isolated
DNA binding domain of the ICP4 pseudorevertant protein was
able to bind to DNA, at least at room temperature (K.E. Allen,
N. DeLuca, R. Everett, unpublished data).
Although substitution K548E had pronounced effects on the
DNA binding and regulatory functions of VZV 140k, the
consequences of two further single mutations in the WLQN
region were more subde. Replacement of 140k residue glutamine
545 with leucine (Q545L) and asparagine 546 with leucine
(N546L) had no apparent effect on DNA binding affinity as
measured by gel retardation analysis. However, the specific
details of their DNA binding interactions, as determined by
DNase I footprinting analysis, significantly differed from those
of either wild type VT2X or VT2XK548E. Mutation Q545L
caused a minor reduction in the transactivation efficiency of the
140k protein, and the N546L mutation resulted in a yet more
pronounced reduction in gD promoter induction. The effects of
these two mutations on the transactivation function are most easily
explained as a consequence of their slightly altered interactions
with DNA, although they may be caused by other factors not
addressed in this study, such as subtle conformational changes
within the domain resulting in defects in other macromolecular
interactions. The effects of these three 140k mutations on DNA
binding support the idea that this WLQN homology region is
directly involved in the DNA binding interaction. Verification
of the importance of the WLQN region will be provided by the
analysis of the effects of these, and further amino acid
substitutions, on the life cycle of the alphaherpesviruses.
The homeodomain forms a stable folded structure that is
capable of binding to DNA by itself (64-66) therefore this 60
residue domain is much smaller than the defined 140k DNA
binding domain (162 residues) (31). However, the structures of
larger variant homeodomains have recendy been determined, for
example, the 'winged-helix' DNA binding motif of proteins such
as HNF-73 (67) is well over 100 amino acids in size. The DNA
binding activity of the HSV-1 ICP4 protein is highly sensitive
to insertion mutations throughout its entire DNA binding domain
(25,26), and it is possible that other additional sequences within
these large domains are directly involved in DNA binding.
Indeed, a HTH motif has been proposed on the basis of secondary
structure predictions further C-terminal to the WLQN region of
the HSV-1 ICP4 protein (26). Several substitutions within this
helical region result in a temperature sensitive DNA binding
phenotype, while two other single mutations in the proposed 'turn'
disrupt DNA binding (K.E. Allen, unpublished data). Although
it is a possibility that this predicted HTH sequence may encode
a structural scaffold which holds the WLQN region in such a
way that it can be stably presented to DNA, it is not uncommon
for proteins to couple additional DNA binding motifs or domains
to increase their affinity or specificity of binding. For example,
prokaryotic HTH proteins such as X repressor, use an extended
region of peptide chain to wrap around the DNA (68). Similarly,
the POU proteins have a conserved 65 — 75 residue segment, the
POU-specific domain, on the N-terminal side of the
homeodomain (69) which contacts the DNA sequence ATGC
adjacent to the homeodomain target sequence (70). Thus each
of the two DNA binding motifs of the POU protein contacts one
half of a non-palindromic bipartite target sequence; the bipartite
nature of the non-palindromic ICP4 consensus binding site (33)
is suggestive of an analogous DNA binding mechanism for the
alphaherpesvirus proteins. Other DNA binding domains found
in association with homeodomains include the paired domain (71),
C2H2 zinc fingers and even additional homeodomains. The
Drosophila Zfli-2 protein, containing three homeodomains and
16 zinc fingers, is an extreme example of this domain coupling
(72). The involvement of several independent structural elements
in the interaction with DNA would be consistent with the large
size of the DNA binding domains of the VZV 140k and HSV-1
ICP4 proteins.
It may transpire that many DNA recognition motifs are
variations on the same theme (73) and DNA binding proteins
have evolved different structural scaffolds to present their DNA
recognition motif to probe the DNA. The 140k alphaherpesvirus
DNA recognition region may be an example of a divergent motif
that has retained a minimum set of residues necessary for its
interaction with DNA. The differences between the potential
WLQN recognition sequence of the 140k protein and the known
types of recognition motifs may facilitate its particular DNA
binding characteristics such as its low DNA binding specificity,
which allows it to bind multiple recognition sequences (31) within
a presumably very wide range of VZV promoters. The details
of the involvement of me WLQN region in the DNA binding
interaction awaits future structural analyses.
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